FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: un (valeur de l'attribut)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
615211000077111 un (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
un est un(e) (attribut) modificateur adjectival général false Inferred relationship Some
un est un(e) (attribut) nombre true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sodium aurothiomalate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely sodium aurothiomalate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Glucose 400 mg/g oral gel Has concentration strength denominator value False un Inferred relationship Some 1
Glucose 400 mg/g oral gel Count of base of active ingredient False un Inferred relationship Some
Glucose 500 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Glucose 500 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Erythromycin estolate 25 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Erythromycin estolate 25 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Fentanyl 200 microgram oromucosal lozenge Has presentation strength denominator value False un Inferred relationship Some 1
Fentanyl 200 microgram oromucosal lozenge Count of base of active ingredient False un Inferred relationship Some
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely erythromycin estolate 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Doxycycline calcium 5 mg/mL oral suspension Count of base of active ingredient False un Inferred relationship Some
Doxycycline calcium 5 mg/mL oral suspension Has concentration strength denominator value False un Inferred relationship Some 1
Albuterol (as albuterol sulfate) 830 microgram/mL solution for inhalation Count of base of active ingredient False un Inferred relationship Some
Albuterol (as albuterol sulfate) 830 microgram/mL solution for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
Albuterol (as albuterol sulfate) 210 microgram/mL solution for inhalation Has concentration strength denominator value False un Inferred relationship Some 1
Albuterol (as albuterol sulfate) 210 microgram/mL solution for inhalation Count of base of active ingredient False un Inferred relationship Some
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely diphenhydramine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely dalbavancin (as dalbavancin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Aripiprazole 10 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Aripiprazole 10 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules Has concentration strength denominator value False un Inferred relationship Some 2
Frangula 80 microgram/mg and Sterculia gum 620 microgram/mg oral granules Has concentration strength denominator value False un Inferred relationship Some 1
Product containing precisely pantoprazole (as pantoprazole sodium) 40 milligram/1 sachet conventional release oral granules (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely pantoprazole (as pantoprazole sodium) 40 milligram/1 sachet conventional release oral granules (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Ceftriaxone (as ceftriaxone sodium) 500 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely baclofen 20 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely baclofen 20 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Estriol 500 microgram vaginal pessary Has presentation strength denominator value False un Inferred relationship Some 1
Estriol 500 microgram vaginal pessary Count of base of active ingredient False un Inferred relationship Some
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Estrone 15 mg/mL suspension for injection Has concentration strength denominator value False un Inferred relationship Some 1
Estrone 15 mg/mL suspension for injection Count of base of active ingredient False un Inferred relationship Some
Siltuximab 400 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Siltuximab 400 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Ciclesonide 50 microgram/actuation nasal spray Count of base of active ingredient False un Inferred relationship Some
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Belimumab 120 mg lyophilized powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Belimumab 120 mg lyophilized powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely lamotrigine 25 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value (attribute) False un Inferred relationship Some 1
Product containing precisely nafcillin (as nafcillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 2
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely cefaclor 375 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Miconazole nitrate 1.2 g vaginal capsule Has presentation strength denominator value False un Inferred relationship Some 1
Miconazole nitrate 1.2 g vaginal capsule Count of base of active ingredient False un Inferred relationship Some
Pegvisomant 15 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Pegvisomant 15 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely prednisolone (as prednisolone sodium phosphate) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength denominator value False un Inferred relationship Some 1
Lamotrigine 100 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Lamotrigine 100 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 4 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely loratadine 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Count of base of active ingredient False un Inferred relationship Some
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some
Sulfanilamide 1.05 g vaginal pessary Count of base of active ingredient False un Inferred relationship Some
Sulfanilamide 1.05 g vaginal pessary Has presentation strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution Has concentration strength numerator value (attribute) False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution Has concentration strength denominator value False un Inferred relationship Some 1
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL oral solution Count of base of active ingredient False un Inferred relationship Some
Miconazole nitrate 100 mg vaginal pessary Count of base of active ingredient False un Inferred relationship Some
Miconazole nitrate 100 mg vaginal pessary Has presentation strength denominator value False un Inferred relationship Some 1
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet Count of base of active ingredient False un Inferred relationship Some
Ondansetron (as ondansetron hydrochloride) 8 mg orodispersible tablet Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False un Inferred relationship Some

Start Previous Page 79 of 217 Next End


This concept is not in any reference sets

Back to Start